In part two of this four-part touchTALKS activity, Dr Elizabeth Smyth shares expert insights on the latest data from ASCO and ESMO GI 2022 on managing patients with ESCC patients with immunotherapy.
Watch here: [ Ссылка ]
------------
This activity is funded by an independent medical education grant from Novartis. This activity is provided by touchIME.
